Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Healthcare Biotechnology Medical Instruments & Supplies
Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the... see more

Recent & Breaking News (TSX:EDT)

Spectral Medical Announces Third Quarter Results and Provides Corporate Update

GlobeNewswire November 8, 2024

Spectral Medical Provides October Tigris Trial Update

GlobeNewswire November 4, 2024

Spectral Medical Provides September Tigris Trial Update

GlobeNewswire October 3, 2024

Spectral Medical Provides August Tigris Trial Update

GlobeNewswire September 3, 2024

Spectral Medical Announces Second Quarter Results and Provides Corporate Update

GlobeNewswire August 9, 2024

Spectral Medical Provides July Tigris Trial Update

GlobeNewswire August 1, 2024

Spectral Medical Inc. Announces Closing of Additional US$1 Million Convertible Notes

GlobeNewswire July 22, 2024

Spectral Medical Inc. Announces Change to Auditor

GlobeNewswire July 11, 2024

Spectral Medical Provides June Tigris Trial Update

GlobeNewswire July 2, 2024

Spectral Medical Inc. Announces Results of Annual Meeting of Shareholders

GlobeNewswire June 7, 2024

Spectral Medical Inc. Announces Closing of Approximately C$8.5 Million Convertible Notes Financing

GlobeNewswire May 30, 2024

Spectral Medical Announces First Quarter Results and Provides Corporate Update

GlobeNewswire May 13, 2024

Spectral Medical Inc. Announces C$8.5 Million Bought Deal Convertible Note Financing

GlobeNewswire May 9, 2024

Spectral Medical Provides April Tigris Trial Update

GlobeNewswire May 6, 2024

Spectral Medical Provides Tigris Trial Update

GlobeNewswire April 10, 2024

Spectral Medical Chair to Retire From the Board of Directors

GlobeNewswire April 2, 2024

Spectral Medical Announces Fourth Quarter and Fiscal 2023 Results and Provides Corporate Update

GlobeNewswire March 28, 2024

Spectral Medical Provides February Tigris Trial Update

GlobeNewswire February 28, 2024

Spectral Medical Announces Amendment and Extension of Exclusive Supply and Distribution Agreement With Baxter Healthcare Corporation

GlobeNewswire February 21, 2024

Spectral Medical Announces Major Milestone by Reaching Its Interim Enrollment Target of 90 Patients

GlobeNewswire February 15, 2024